# US 2008/0188830 A1 · Selectively reinforced medical devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188830 A1
- Document ID: US20080188830A1
- Status: Published application
- Kind: A1
- Application number: 11/708,162
- Filed: 2007-02-06
- Published: 2008-08-07
- Earliest claimed: 2007-02-06
- Assignees: Arrow International, Inc.
- Inventors: Joel Rosenblatt; Michael E. Starsinic; Hiep Do
- Web page: https://patentgrep.com/patent/US20080188830A1

## CPC

- A61M 25/0054: {with regions for increasing flexibility}
- A61M 25/0029: {characterized by features relating to least one lumen located at the middle part of the catheter, e.g. slots, flaps, valves, cuffs, apertures, notches, grooves or rapid exchange ports (catheter shaft surface irregularities A61M2025/006)}
- A61M 2025/0031: {characterized by lumina for withdrawing or delivering, i.e. used for extracorporeal circuit treatment}
- A61M 2025/0037: {characterized by lumina being arranged side-by-side}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A medical device including a component made of polyurethane having a reinforced pattern comprising polytetramethylene ether glycol.

## Claims

### Claim 1

A medical device comprising:
a component made of polyurethane having a reinforced pattern comprising polytetramethylene ether glycol.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein the medical device is a catheter.

### Claim 3 (depends on 2)

The medical device of claim 2, wherein the component is a main body portion of the catheter comprising at least one lumen and the main body portion has a proximal end portion and a distal end portion.

### Claim 4 (depends on 3)

The medical device of claim 3, wherein the reinforced pattern comprises at least one strip extending longitudinally from the proximal end portion to the distal end portion of the main body portion of the catheter.

### Claim 5 (depends on 3)

The medical device of claim 3, wherein the reinforced pattern is disposed at the distal end portion of the main body portion of the catheter.

### Claim 6 (depends on 3)

The medical device of claim 3, wherein the reinforced pattern is disposed at the proximal end portion of the main body portion of the catheter.

### Claim 7 (depends on 1)

The medical device of claim 1, wherein the reinforced pattern is a blend of the polytetramethylene ether glycol and the polyurethane, with the polytetramethylene ether glycol being present in the blend at 1% to 5% by weight.

### Claim 8 (depends on 1)

The medical device of claim 1, further comprising an extended release material incorporated in the component.

### Claim 9 (depends on 8)

The medical device of claim 8, wherein the release material is mixed with the polytetramethylene ether glycol.

### Claim 10 (depends on 9)

The medical device of claim 9, wherein the extended release material is dissolved in the polytetramethylene ether glycol using a solvent at a temperature above ambient temperature.

### Claim 11 (depends on 8)

The medical device of claim 8, wherein the extended release material is an antimicrobial agent.

### Claim 12 (depends on 11)

The medical device of claim 11, wherein the antimicrobial agent comprises any one or more of a guanidium, a biguanide, a bipyridine, a phenoxide antiseptic, an alkyl oxide, an aryl oxide, a thiol, an aliphatic amine, an aromatic amine, bismuth, chlorxylenol, protamine, colofoctol, chloroxylenol, triclosan, gendine, genlenol, genlosan, genfoctol, octenidine, chlorhexidine, alexidine, hexamidine, silver, silver sulfadiazine, chlorhexidine-silver sulfadiazine, chlorhexidine acetate, chlorhexidine gluconate, chlorhexidine hydrochloride, chlorhexidine and propanol, chlorhexidine base and chlorhexidine acetate, povidone-iodine, cefazolin, teicoplanin, vancomycin, an aminosterol, a magainin, a furanone, a halogenated furanone, a triarylmethane dye, a monoazo dye, a diazo dye, an indigoid dye, a xanthene dye, a fluorescein dye, an anthraquinone dye, a quinoline dye, gentian violet, crystal violet, ethyl violet, brilliant green, methylene blue, rifampicin, taurolidone, 5-fluorouracil, Adriamycin, a tetracycline, minocycline, clindamycin, rifampin-minocycline, and salts thereof.

### Claim 13 (depends on 12)

The medical device of claim 12, wherein the antimicrobial agent comprises chlorhexidine.

### Claim 14 (depends on 1)

The medical device of claim 1, wherein the component comprises at least one of antithrombogenic and anti-inflammatory agents.

### Claim 15

A method of forming a medical device, comprising:
forming polyurethane into a component of the medical device; and
forming a reinforced pattern in the component, the reinforced pattern comprising polytetramethylene ether glycol.

### Claim 16 (depends on 15)

The method of claim 15, wherein the reinforced pattern is formed by coextrusion of the polytetramethylene ether glycol with the polyurethane.

### Claim 17 (depends on 16)

The method of claim 16, wherein the reinforced pattern is formed by blending the polytetramethylene ether glycol with the polyurethane.

### Claim 18 (depends on 15)

The method of claim 15, wherein the reinforced pattern is formed by exposing the component to the polytetramethylene ether glycol after formation of the component.

### Claim 19 (depends on 15)

The method of claim 15, wherein the medical device is a catheter.

### Claim 20 (depends on 19)

The method of claim 19, wherein the component is a main body portion of the catheter comprising at least one lumen and the main body portion has a proximal end portion and a distal end portion.

### Claim 21 (depends on 20)

The method of claim 20, wherein the step of forming a reinforced pattern comprises forming at least one reinforced strip extending longitudinally from the proximal end portion to the distal end portion of the main body portion of the catheter.

### Claim 22 (depends on 20)

The method of claim 20, wherein the step of forming a reinforced pattern comprises forming the reinforced pattern at the distal end portion of the main body portion of the catheter.

### Claim 23 (depends on 20)

The method of claim 20, wherein the step of forming a reinforced pattern comprises forming the reinforced pattern at the proximal end portion of the main body portion of the catheter.

### Claim 24 (depends on 15)

The method of claim 15, further comprising incorporating an extended release material into the medical device.

### Claim 25 (depends on 24)

The method of claim 24, wherein the step of incorporating comprises mixing the release material with the polytetramethylene ether glycol.

### Claim 26 (depends on 24)

The method of claim 24, wherein the step of incorporating comprises dissolving the release material in the polytetramethylene ether glycol using a solvent at a temperature above ambient temperature.

### Claim 27 (depends on 24)

The method of claim 24, wherein the extended release material is an antimicrobial agent.

### Claim 28 (depends on 27)

The method of claim 27, wherein the antimicrobial agent comprises any one or more of a guanidium, a biguanide, a bipyridine, a phenoxide antiseptic, an alkyl oxide, an aryl oxide, a thiol, an aliphatic amine, an aromatic amine, bismuth, chlorxylenol, protamine, colofoctol, chloroxylenol, triclosan, gendine, genlenol, genlosan, genfoctol, octenidine, chlorhexidine, alexidine, hexamidine, silver, silver sulfadiazine, chlorhexidine-silver sulfadiazine, chlorhexidine acetate, chlorhexidine gluconate, chlorhexidine hydrochloride, chlorhexidine and propanol, chlorhexidine base and chlorhexidine acetate, povidone-iodine, cefazolin, teicoplanin, vancomycin, an aminosterol, a magainin, a furanone, a halogenated furanone, a triarylmethane dye, a monoazo dye, a diazo dye, an indigoid dye, a xanthene dye, a fluorescein dye, an anthraquinone dye, a quinoline dye, gentian violet, crystal violet, ethyl violet, brilliant green, methylene blue, rifampicin, taurolidone, 5-fluorouracil, Adriamycin, a tetracycline, minocycline, clindamycin, rifampin-minocycline, and salts thereof.

### Claim 29 (depends on 28)

The method of claim 28, wherein the antimicrobial agent comprises chlorhexidine.

### Claim 30 (depends on 15)

The method of claim 15, further comprising adding at least one of antithrombogenic and anti-inflammatory agents to the component.
